An Open Label Pilot Study on the Tolerability of Duloxetine in the Treatment of Depressed Patients With Parkinson's Disease.

Trial Profile

An Open Label Pilot Study on the Tolerability of Duloxetine in the Treatment of Depressed Patients With Parkinson's Disease.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Major depressive disorder
  • Focus Adverse reactions
  • Sponsors Eli Lilly
  • Most Recent Events

    • 28 Jul 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
    • 28 Jul 2009 Actual patient number (151) added as reported by ClinicalTrials.gov.
    • 28 Jul 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top